Funds with Big Goldman Sachs and Morgan Stanley Stakes
Many financial stocks have posted gains. Does your fund own them?
Many financial stocks have posted gains. Does your fund own them?
Major stock indexes are up by more than 20% over the past two months, and many of the stocks benefiting most from this surge are the same ones that suffered the most in last year's terrible market slide. For example, energy and materials stocks fell hard in the second half of 2008 amid plunging commodity prices, but they're on fire the past few months, with mining giants such as Rio Tinto and Freeport-McMoRan Copper & Gold (FCX) up more than 100% for the year. Big technology stocks such as Apple (AAPL) and Google (GOOG) got hammered in 2008 but are up big in 2009, as we noted recently.
Of course, financials were at the heart of last year's storm, and many financial stocks have posted big gains in the past couple of months--admittedly from very depressed levels. Banking giants Citigroup (C) and Bank of America (BAC) have tripled in price from the lows they hit in early March, when it was widely feared that they would have to be nationalized, and most big regional banks have also rebounded, albeit less dramatically. Two other financial giants that have come up off the canvas after being beaten down are Goldman Sachs (GS) and Morgan Stanley (MS), the two big Wall Street investment banks left standing after the turmoil that claimed Bear Stearns, Lehman Brothers, and Merrill Lynch last year. Both companies have continued to report big quarterly losses, but the pessimism surrounding them has eased amid tentative signs that the U.S. economy and banking system are stabilizing. As of May 6, Goldman Sachs was up 61% for the year to date and Morgan Stanley was up 72%, though both are still down more than 30% over the past year.
Earlier this year, when pessimism still reigned, we looked at which mutual funds had the biggest stakes in big multinational banks and major regional banks. Not surprisingly, we found that these funds' returns had suffered significantly. More recently, after the financial rebound had started, we revisited these funds and found that their one-month returns had improved dramatically, though their one-year returns still looked ugly.
We thought that it would be interesting to take a similar look at the funds with the biggest stakes in Goldman Sachs and Morgan Stanley. Back in September 2008, right after the collapse of Lehman Brothers, we made separate lists of funds that were heavy in Goldman and in Morgan Stanley. (You can see those lists here.) This time, we looked at funds with the biggest combined percentage of their portfolio in the two stocks. Not surprisingly, several of the funds on the initial list are financials-sector funds, but we decided to restrict the final list to diversified funds, as well as those with at least $50 million in assets. We also eliminated funds that are clones of others on the list.
The results are shown in the table below. It includes each fund's category, the size of its asset base, the combined percentage of its portfolio in Goldman Sachs and Morgan Stanley as of the most recent portfolio, its percentile ranking in its category for the year to date as of May 6, and its percentile ranking for the past 12 months, also as of May 6.
Funds with Big Goldman Sachs and Morgan Stanley Stakes | |||||
Category | Size ($M) | GS/MS % | % Rank Cat YTD | % Rank Cat 1 yr | |
Janus Orion (JORNX) | Mid-cap growth | 2,171.4 | 7.66 | 15 | 90 |
Wells Fargo Adv Lg Co Gr | Large-growth | 574.9 | 7.62 | 12 | 5 |
Natixis CGM Adv Target Eq | Large-growth | 844.7 | 6.45 | 95 | 89 |
Janus Growth & Income (JAGIX) | Large-growth | 2,846.5 | 6.05 | 21 | 54 |
MassMutual Sel Focused Val (MFVAX) | Large-blend | 416.1 | 5.66 | 1 | 14 |
JPMorgan Value Opp | Large-value | 419.4 | 5.65 | 28 | 62 |
Parnassus (PARNX) | Large-growth | 224.0 | 4.39 | 4 | 2 |
Jennison Value | Large-value | 625.0 | 4.33 | 4 | 57 |
Marsico Focus (MFOCX) | Large-growth | 2,028.4 | 4.18 | 70 | 67 |
Hartford Capital Apprec (ITHAX) | Large-blend | 13,562.3 | 4.03 | 5 | 87 |
This group is looking pretty good so far in 2009. Eight of the 10 funds are beating their categories for the year to date, with four ranking in the top decile and another couple just missing it. This strong performance isn't solely due to Goldman Sachs and Morgan Stanley, of course, but it's surely significant that nine of these funds (all except Jennison Value ) are overweight in financial stocks relative to their category, with several having twice the financial weighting of their average peer. That's undoubtedly also a big reason why most of these funds are trailing their categories over the past year, when financial stocks as a group are still way down.
In contrast, it's interesting to note how funds betting against Goldman and Morgan Stanley have suffered this year. Fifteen mutual funds in Morningstar's database, mostly long-short funds, have short exposure to Goldman Sachs and/or Morgan Stanley, meaning that they benefit if those stocks go down and are hurt if the stocks go up. Five of these funds--American Century Long-Short Market Neutral , Grizzly Short (GRZZX), DWS Disciplined Market Neutral , Dover Long/Short Sector , and UBS PACE Alternative Strategies (PASIX)-- have at least 0.50% short exposure to the two stocks. All five of these funds are doing significantly worse than their category for the year to date, and the American Century fund, whose 3.62% short exposure to Goldman Sachs is by far the largest, ranks in the bottom decile of the long-short category. On the other hand, all five of these funds have beaten their categories over the past year.
Of course, the short-term results that we're discussing here aren't too significant in the long term, but they do illustrate how volatile the past year's market has been, and how one month's big losers can be big winners the next month (and vice versa). Morningstar's stock analysts see both Goldman Sachs and Morgan Stanley as being about fairly valued at their current levels, but with very high fair value uncertainty, reflecting the continuing questions about the stability of the U.S. banking system. Most of the funds with big stakes in these two stocks have done well lately, but that could change quickly.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.